VinitBharatiMahajanMDPh.D.

Retinal Disease

Associate Professor, Department of Ophthalmology, Stanford University

Dr. Mahajan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

UCLA David Geffen School of Medicine/UCLA Medical Center/UCLA Stein and Doheny Eye InstitutesResidency, Ophthalmology, 2002 - 2006
Los Angeles County-Harbor-UCLA Medical CenterInternship, Transitional Year, 2001 - 2002
University of California, Irvine, School of MedicineClass of 2001

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

PubMed

13 citations
Investigation of Cas9 antibodies in the human eye.
Marcus A Toral, Carsten T Charlesworth, Benjamin Ng, Teja Chemudupati, Shota Homma
Nature Communications. 2022-02-25
133 citations
Viral Delivery Systems for CRISPR.
Christine L. Xu, Merry Z. C. Ruan, Vinit B. Mahajan, Stephen H. Tsang
Viruses. 2019-01-04
63 citations
Reprogramming metabolism by targeting sirtuin 6 attenuates retinal degeneration
Lijuan Zhang, Jianhai Du, Sally Justus, Chun-Wei Hsu, Luis Bonet-Ponce
The Journal of Clinical Investigation. 2016-12-01